Back to results
US 8,148,351 B2Granted
Enteropathy ameliorating composition
AssigneeTaiyo Kagaku Co., Ltd.
InventorsTakeo Yokawa, Noriyuki Ishihara
Life of this patent
Estimating the term…
Abstract
The present invention relates to a composition for preventing, ameliorating or treating a bowel disease, comprising galactomannan and/or arabinogalactan; a liquid food for preventing, ameliorating or treating a bowel disease, characterized in that the liquid food comprises a protein and galactomannan and/or arabinogalactan; and a composition for preventing, ameliorating or treating an irritable bowel syndrome, comprising degraded galactomannan.
Claims11
A method for ameliorating or treating an inflammatory bowel disease, comprising
- administering a composition comprising galactomannan in an amount sufficient to lower the activity of myeloperoxidase and TNF-α to a patient suffering from said inflammatory bowel disease, wherein said galactomannan is a degraded galactomannan having an average molecular weight of from 8,000 to 50,000 and a viscosity of 10 mPa·s or less, as determined by 0.5(w/v) % aqueous solution of the degraded galactomannan,
- wherein the degraded galactomannan is produced by hydrolyzing guar gum with β-mannanase. without further chemical processing, and
- wherein the administering step includes administering the composition having 5-100% by weight of galactomannan in an amount of 1 to 70g/day/adult.
Dependencies are inferred from the claim text.